CLEC4C

CLEC4C (C-type Lectin Domain Family 4 Member C), also known as BDCA-2 (Blood Dendritic Cell Antigen 2), is a protein that in humans is encoded by the CLEC4C gene. This protein is a member of the C-type lectin/C-type lectin-like domain (CTLD) superfamily. CLEC4C is specifically expressed in plasmacytoid dendritic cells (pDCs), which are a specialized type of dendritic cells involved in antiviral responses and the production of interferons.

Function

CLEC4C plays a crucial role in the immune system. It is involved in the recognition of glycan structures on the surface of pathogens or apoptotic cells by pDCs. Upon binding to its ligands, CLEC4C inhibits the production of interferon-alpha (IFN-α) by pDCs, thus playing a regulatory role in the innate immune response. This inhibition is critical for maintaining immune homeostasis and preventing excessive inflammatory responses that could lead to autoimmune diseases.

Structure

The CLEC4C protein contains a single C-type lectin-like domain (CTLD) at its extracellular N-terminus, a transmembrane region, and a short cytoplasmic tail. The CTLD is responsible for ligand recognition and binding. The precise structure of CLEC4C and its ligands are subjects of ongoing research, aiming to understand the molecular basis of its function and regulation.

Clinical Significance

Given its role in modulating the immune response, CLEC4C is of interest in the study of autoimmune diseases, such as lupus erythematosus and psoriasis, where dysregulation of the immune system plays a critical role. Therapeutic targeting of CLEC4C, either by agonists or antagonists, could potentially modulate pDC activity and, thereby, the production of IFN-α, offering new avenues for the treatment of these conditions.

Additionally, the specific expression of CLEC4C on pDCs makes it a useful marker for the identification and study of this cell type in the context of disease and immunotherapy.

Research Directions

Research on CLEC4C is focused on elucidating its ligands and signaling pathways to better understand its role in immune regulation and its potential as a therapeutic target. Studies are also exploring the role of CLEC4C in the context of infections, cancer, and vaccination, where modulation of the immune response can have therapeutic benefits.

See Also

• Dendritic cell
• C-type lectin
• Autoimmune disease
• Interferon

External Links

• NCBI Gene: CLEC4C
• UniProt: CLEC4C

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian